• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经活检证实的恶性高血压伴严重肾损伤的特征与结局:一项回顾性研究

Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study.

作者信息

Haridasan Satish, Priyamvada P S, Puthiyottil Dhanin, Pradeep Arjun, Parameswaran Sreejith, Srinivas B H, Ganesh Rajesh Nachiappa

机构信息

Department of Nephrology, JIPMER, Puducherry, India.

Daya General Hospital, Thrissur, Kerala, India.

出版信息

Indian J Nephrol. 2021 Sep-Oct;31(5):467-473. doi: 10.4103/ijn.IJN_187_20. Epub 2021 Apr 10.

DOI:10.4103/ijn.IJN_187_20
PMID:34880557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8597798/
Abstract

BACKGROUND

Although malignant hypertension begets multiple target organ damage, there is limited data on patients with severe renal injury and evident malignant hypertension in renal histopathology.

METHODS

We assessed the baseline demographic, histopathological findings and clinical outcomes in this retrospective analysis of patients with biopsy-proven malignant hypertension.

RESULTS

Thirty cases were analysed, the mean age of patients was 40 ± 11.5 years, 28 (93.3%) were males and the average systolic and diastolic blood pressures at hospitalisation were 197.04 ± 24.14 and 117.41 ± 18.31 mmHg, respectively. Severe retinopathy was seen in 10 (33.3%). The median eGFR at admission was 6.3 (IQR 4.4-9.15) mL/min and 21 (72.4%) needed dialysis. Nine (30%) cases with glomerular crescents were having the primary glomerular disease (7 IgAN, 1 C3 glomerulonephritis, 1 membranoproliferative glomerulonephritis) and 17 (56.6%) had thrombotic microangiopathy. Three-month ESRD free survival was 34.5% ( = 10) and the ESRD cohort had more incidence of dialysis requiring kidney injury at presentation (94.4% vs. 40% in the non-ESRD cohort). Patient survival at 1 year was 50%. Isolated malignant hypertension, differed from others with regard to lesser incidence of severe retinopathy, less glomerular sclerosis (29.61 ± 15.86 vs. 48.45% ± 30.78; = 0.03), absence of crescents ( = 0.02), more incidence of tuft wrinkling (100% vs. 35%, = 0.00) and total vessel occlusion ( = 0.02).

CONCLUSION

Clinicopathologically, accelerated essential hypertension differs from hypertension of glomerular disease. Degree of kidney injury at presentation is risk predictor for long-term morbidity in malignant hypertension.

摘要

背景

尽管恶性高血压会导致多靶器官损害,但关于肾组织病理学中存在严重肾损伤及明显恶性高血压患者的数据有限。

方法

在这项对经活检证实为恶性高血压患者的回顾性分析中,我们评估了基线人口统计学、组织病理学结果及临床结局。

结果

分析了30例患者,患者的平均年龄为40±11.5岁,28例(93.3%)为男性,住院时平均收缩压和舒张压分别为197.04±24.14 mmHg和117.41±18.31 mmHg。10例(33.3%)出现严重视网膜病变。入院时中位估算肾小球滤过率(eGFR)为6.3(四分位间距4.4 - 9.15)mL/分钟,21例(72.4%)需要透析。9例(30%)有肾小球新月体形成的病例患有原发性肾小球疾病(7例IgA肾病、1例C3肾小球肾炎、1例膜增生性肾小球肾炎),17例(56.6%)有血栓性微血管病。3个月无终末期肾病(ESRD)生存率为34.5%(n = 10),ESRD队列在就诊时需要透析的肾损伤发生率更高(94.4% vs.非ESRD队列中的40%)。1年时患者生存率为50%。孤立性恶性高血压与其他类型在严重视网膜病变发生率较低、肾小球硬化较少(29.61±15.86 vs. 48.45%±30.78;P = 0.03)、无新月体形成(P = 0.02)、毛细血管襻皱缩发生率更高(100% vs. 35%,P = 0.00)及小血管完全闭塞(P = 0.02)方面存在差异。

结论

在临床病理方面,急进性原发性高血压与肾小球疾病性高血压不同。就诊时的肾损伤程度是恶性高血压长期发病的风险预测指标。

相似文献

1
Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study.经活检证实的恶性高血压伴严重肾损伤的特征与结局:一项回顾性研究
Indian J Nephrol. 2021 Sep-Oct;31(5):467-473. doi: 10.4103/ijn.IJN_187_20. Epub 2021 Apr 10.
2
Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.经活检证实的高血压性肾硬化患者的临床病理特征及预后:一项回顾性队列研究
BMC Nephrol. 2016 Apr 11;17:42. doi: 10.1186/s12882-016-0254-2.
3
A Rare Presentation of Immunoglobulin A Nephropathy: Acute Kidney Injury.免疫球蛋白A肾病的罕见表现:急性肾损伤
Nephron. 2017;137(1):8-14. doi: 10.1159/000470852. Epub 2017 Jul 26.
4
Clinical outcomes of IgA nephropathy patients with different proportions of crescents.不同新月体比例的IgA肾病患者的临床结局
Medicine (Baltimore). 2017 Mar;96(11):e6190. doi: 10.1097/MD.0000000000006190.
5
A validation study of crescents in predicting ESRD in patients with IgA nephropathy.IgA 肾病患者新月体预测终末期肾病的验证研究。
J Transl Med. 2018 May 3;16(1):115. doi: 10.1186/s12967-018-1488-5.
6
Prognostic factors in glomerular diseases with crescents.伴有新月体的肾小球疾病的预后因素
Rom J Intern Med. 2019 Sep 1;57(3):254-261. doi: 10.2478/rjim-2019-0010.
7
[Clinical and pathological analysis of IgA nephropathy with acute kidney injury].IgA肾病合并急性肾损伤的临床与病理分析
Zhonghua Er Ke Za Zhi. 2016 Aug;54(8):610-3. doi: 10.3760/cma.j.issn.0578-1310.2016.08.012.
8
Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis.恶性高血压:一种预后较差的IgA肾病表现类型。
Nefrologia. 2015;35(1):42-9. doi: 10.3265/Nefrologia.pre2014.Oct.12735.
9
Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.抗肾小球基底膜病的临床病理特征及不良预后的预测因素:一项十五年单中心经验。
Ren Fail. 2021 Dec;43(1):79-89. doi: 10.1080/0886022X.2020.1854301.
10
Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis.重症狼疮伴急进性肾小球肾炎患者的病理谱及肾脏预后
Rheumatol Int. 2015 Apr;35(4):709-17. doi: 10.1007/s00296-014-3140-x. Epub 2014 Oct 4.

本文引用的文献

1
Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort.恶性高血压:来自波尔多队列的诊断、治疗和预后经验。
J Hypertens. 2019 Feb;37(2):316-324. doi: 10.1097/HJH.0000000000001913.
2
Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.经活检证实的高血压性肾硬化患者的临床病理特征及预后:一项回顾性队列研究
BMC Nephrol. 2016 Apr 11;17:42. doi: 10.1186/s12882-016-0254-2.
3
From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.从恶性高血压到高血压急症伴多器官功能障碍:一个针对古老但依然危险的急症的现代定义。
J Hum Hypertens. 2016 Aug;30(8):463-6. doi: 10.1038/jhh.2015.112. Epub 2015 Nov 19.
4
Cumulative Effects of Several Target Organ Damages in Risk Assessment in Hypertension.高血压风险评估中多种靶器官损害的累积效应
Am J Hypertens. 2016 Feb;29(2):234-44. doi: 10.1093/ajh/hpv098. Epub 2015 Jun 25.
5
Retinal and choroidal changes with severe hypertension and their association with visual outcome.重度高血压患者的视网膜和脉络膜变化及其与视力预后的关系。
Invest Ophthalmol Vis Sci. 2014 Nov 13;55(12):7775-85. doi: 10.1167/iovs.14-14915.
6
Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China.预测肾血栓性微血管病预后的临床及肾活检结果:来自中国一家单中心的大型队列研究
ScientificWorldJournal. 2014;2014:680502. doi: 10.1155/2014/680502. Epub 2014 Aug 11.
7
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study.恶性高血压患者的长期肾脏预后:一项回顾性队列研究。
BMC Nephrol. 2012 Jul 30;13:71. doi: 10.1186/1471-2369-13-71.
8
Malignant hypertension: a rare problem or is it underdiagnosed?恶性高血压:罕见问题还是诊断不足?
Curr Vasc Pharmacol. 2010 Nov;8(6):775-9. doi: 10.2174/157016110793563834.
9
Long-term renal survival in malignant hypertension.恶性高血压的长期肾脏存活率。
Nephrol Dial Transplant. 2010 Oct;25(10):3266-72. doi: 10.1093/ndt/gfq143. Epub 2010 Mar 17.
10
Severe renal failure and microangiopathic hemolysis induced by malignant hypertension--case series and review of literature.恶性高血压所致严重肾衰竭和微血管病性溶血——病例系列及文献综述
Clin Nephrol. 2010 Feb;73(2):147-52. doi: 10.5414/cnp73147.